Continuation of the Prescription Drug Event (PDE) Reports and PDE Analysis Reporting Initiatives for the 2018 Benefit Year
Guidance for Medicare Part D plan sponsors. The purpose of this memorandum is to announce the continuation of two reporting initiatives for the 2018 benefit_x000D_
year that support CMS’s efforts to improve the accuracy of sponsors’ PDE data.
Issued by: Centers for Medicare & Medicaid Services (CMS)
Issue Date: April 10, 2018
HHS is committed to making its websites and documents accessible to the widest possible audience, including individuals with disabilities. We are in the process of retroactively making some documents accessible. If you need assistance accessing an accessible version of this document, please reach out to the guidance@hhs.gov.
DISCLAIMER: The contents of this database lack the force and effect of law, except as authorized by law (including Medicare Advantage Rate Announcements and Advance Notices) or as specifically incorporated into a contract. The Department may not cite, use, or rely on any guidance that is not posted on the guidance repository, except to establish historical facts.